<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2006-3-3-7</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-462</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>КАЛПРОТЕКТИН В СКРИНИНГОВОЙ ДИАГНОСТИКЕ РАКА ЖЕЛУДКА</article-title><trans-title-group xml:lang="en"><trans-title>CALPROTECTIN IN SCREENING DIAGNOSTICS OF GASTRIC CARCINOMA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлова</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhailova</surname><given-names>E. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution><country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>28</day><month>09</month><year>2006</year></pub-date><volume>0</volume><issue>3</issue><fpage>46</fpage><lpage>51</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Михайлова Е.И., 2006</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="ru">Михайлова Е.И.</copyright-holder><copyright-holder xml:lang="en">Mikhailova E.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/462">https://journal.gsmu.by/jour/article/view/462</self-uri><abstract><p>Кальпротектин - белок, содержащийся в большом количестве в цитоплазме нейтрофильных гранулоцитов, активированных макрофагов и, в меньшей степени, моноцитов. Биологическая роль кальпротектина не выяснена, имеются данные о его антимикробной, кальций-связывающей и регуляторной активности. Основным моментом, на котором было сфокусировано внимание большинства исследователей, явилось разграничение функциональной и органической патологии кишечника. Он считается более точным индикатором патологического процесса, прежде всего, воспалительного, чем СОЭ и C-реактивный белок и позволяет эффективно исключить органическую патологию кишечника. В доступной нам литературе мы не нашли данных об эффективности использования фекального калпротектина в диагностике органической, в том числе и опухолевой патологии желудка. Целью нашего исследования явилось изучение диагностической точности фекального калпротектина в качестве скринингового метода в диагностике рака желудка. Мы изучали 43 больных раком желудка, 36 пациентов с гастродуоденальными язвами и 27 пациентов с желудочными диспепсиями в возрасте от 17 и до 80 лет (средний возраст 45±6,82 лет). Наше исследование показало, что уровень фекального калпротектина достоверно выше при раке желудка, чем при желудочной диспепсии и не отличается от такового при гастродуоденальных язвах. Тест высоко специфичен, что особенно важно для скрининговой диагностики.</p></abstract><trans-abstract xml:lang="en"><p>Calprotectin is a protein which is available in big amount in the cytoplasm of neutrophilic granulocytes, activated macrophages and, to a lesser degree, monocytes. Biological value of the calprotectin is not clear, there are evidences of its antimicrobial, calcium-binding and regulatory action. The main focus of researchers was division of functional and organic pathologies of the intestine. It is considered to be more precise indicator of the pathological process, first of all, inflammatory, than ESR and C-reactive protein and allows to exclude organic pathology of the intestine. In the references available there has been no data on the effectiveness of fecal calprotectin use to diagnose organic pathology of the stomach including tumor formation. We have investigated the efficiency of fecal calprotectin use in the screening diagnostics of gastric cancer in 43 patients with gastric cancer, 36 patients with gastroduodenal ulcers and 27 patients aged 17-80 with gastric dyspepsia (average age 45±6,82 years old). It was revealed that the level of fecal calprotectin is significantly higher at gastric cancer than at gastric dyspepsia, and does not differ from the same analysis at gastroduodenal ulcers. The analysis is highly specific, that makes it useful in the screening diagnostics of the gastric cancer.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак желудка</kwd><kwd>скрининговая диагностика</kwd><kwd>фекальный калпротектин</kwd><kwd>gastric cancer</kwd><kwd>screening methods of diagnostics</kwd><kwd>fecal calprotectin</kwd></kwd-group><kwd-group xml:lang="en"><kwd>рак желудка</kwd><kwd>скрининговая диагностика</kwd><kwd>фекальный калпротектин</kwd><kwd>gastric cancer</kwd><kwd>screening methods of diagnostics</kwd><kwd>fecal calprotectin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Флетчер, Р. Клиническая эпидемиология / Р. Флетчер [и др.]. - М. : Медиа Сфера, 1998. - 229 с.</mixed-citation><mixed-citation xml:lang="en">Флетчер, Р. Клиническая эпидемиология / Р. Флетчер [и др.]. - М. : Медиа Сфера, 1998. - 229 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Oortwijn, W. Introduction: mass screening, health technology assessment, and health policy in some European countries / W. Oortwijn [et al.] // Int. J. Technol. Assess. Health Care. - 2001. - Vol. 17, № 3. - P. 269-274.</mixed-citation><mixed-citation xml:lang="en">Oortwijn, W. Introduction: mass screening, health technology assessment, and health policy in some European countries / W. Oortwijn [et al.] // Int. J. Technol. Assess. Health Care. - 2001. - Vol. 17, № 3. - P. 269-274.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gazelle, G.S. Screening for Colorectal Cancer / G.S. Gazelle [et al.] // Radiology. - 2000. - Vol. 215, № 2. - Р. 327-335.</mixed-citation><mixed-citation xml:lang="en">Gazelle, G.S. Screening for Colorectal Cancer / G.S. Gazelle [et al.] // Radiology. - 2000. - Vol. 215, № 2. - Р. 327-335.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dolwani, S. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology / S. Dolwani [et al.] // Aliment. Pharmacol. Ther. - 2004. - № 20. - Р. 615-621.</mixed-citation><mixed-citation xml:lang="en">Dolwani, S. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology / S. Dolwani [et al.] // Aliment. Pharmacol. Ther. - 2004. - № 20. - Р. 615-621.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hoff, G. Testing for fecal calprotectin in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSureOBT) / G. Hoff [et al.] // Gut. - 2004. - № 53. - Р. 1329-1333.</mixed-citation><mixed-citation xml:lang="en">Hoff, G. Testing for fecal calprotectin in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSureOBT) / G. Hoff [et al.] // Gut. - 2004. - № 53. - Р. 1329-1333.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Johne, B. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method / B. Johne [et al.] // Scand. J. Gastroenterol. - 2001. - № 36. - Р. 291-296.</mixed-citation><mixed-citation xml:lang="en">Johne, B. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method / B. Johne [et al.] // Scand. J. Gastroenterol. - 2001. - № 36. - Р. 291-296.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
